These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18618081)

  • 21. Increased sensitivity to thiopurines in methylthioadenosine phosphorylase-deleted cancers.
    Coulthard SA; Redfern CP; Vikingsson S; Lindqvist-Appell M; Skoglund K; Jakobsen-Falk I; Hall AG; Taylor GA; Hogarth LA
    Mol Cancer Ther; 2011 Mar; 10(3):495-504. PubMed ID: 21282358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of expression of MTAP in uncommon T-cell lymphomas.
    Bertino JR; Lubin M; Johnson-Farley N; Chan WC; Goodell L; Bhagavathi S
    Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):306-9. PubMed ID: 23040436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas.
    Illei PB; Rusch VW; Zakowski MF; Ladanyi M
    Clin Cancer Res; 2003 Jun; 9(6):2108-13. PubMed ID: 12796375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance.
    Li CF; Fang FM; Kung HJ; Chen LT; Wang JW; Tsai JW; Yu SC; Wang YH; Li SH; Huang HY
    Oncotarget; 2014 Nov; 5(22):11428-41. PubMed ID: 25426549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concordant loss of MTAP and p16/CDKN2A expression in gastroesophageal carcinogenesis: evidence of homozygous deletion in esophageal noninvasive precursor lesions and therapeutic implications.
    Powell EL; Leoni LM; Canto MI; Forastiere AA; Iocobuzio-Donahue CA; Wang JS; Maitra A; Montgomery E
    Am J Surg Pathol; 2005 Nov; 29(11):1497-504. PubMed ID: 16224217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma.
    García-Castellano JM; Villanueva A; Healey JH; Sowers R; Cordon-Cardo C; Huvos A; Bertino JR; Meyers P; Gorlick R
    Clin Cancer Res; 2002 Mar; 8(3):782-7. PubMed ID: 11895909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circadian pharmacology of L-alanosine (SDX-102) in mice.
    Li XM; Kanekal S; Crépin D; Guettier C; Carrière J; Elliott G; Lévi F
    Mol Cancer Ther; 2006 Feb; 5(2):337-46. PubMed ID: 16505107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene deletion chemoselectivity: codeletion of the genes for p16(INK4), methylthioadenosine phosphorylase, and the alpha- and beta-interferons in human pancreatic cell carcinoma lines and its implications for chemotherapy.
    Chen ZH; Zhang H; Savarese TM
    Cancer Res; 1996 Mar; 56(5):1083-90. PubMed ID: 8640765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I study of L-alanosine (NSC 15353).
    Goldsmith MA; Ohnuma T; Spigelman M; Greenspan EM; Holland JF
    Cancer; 1983 Feb; 51(3):378-80. PubMed ID: 6821823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical diagnosis of methylthioadenosine phosphorylase (MTAP) deficiency in non-small cell lung carcinoma.
    Watanabe F; Takao M; Inoue K; Nishioka J; Nobori T; Shiraishi T; Kaneda M; Sakai T; Yada I; Shimpo H
    Lung Cancer; 2009 Jan; 63(1):39-44. PubMed ID: 18555557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylthioadenosine phosphorylase gene deletions are frequently detected by fluorescence in situ hybridization in conventional chondrosarcomas.
    Chow WA; Bedell V; Gaytan P; Borden E; Goldblum J; Hicks D; Slovak ML
    Cancer Genet Cytogenet; 2006 Apr; 166(2):95-100. PubMed ID: 16631464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic cloning of methylthioadenosine phosphorylase: a purine metabolic enzyme deficient in multiple different cancers.
    Nobori T; Takabayashi K; Tran P; Orvis L; Batova A; Yu AL; Carson DA
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):6203-8. PubMed ID: 8650244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MTAP is an independent prognosis marker and the concordant loss of MTAP and p16 expression predicts short survival in non-small cell lung cancer patients.
    Su CY; Chang YC; Chan YC; Lin TC; Huang MS; Yang CJ; Hsiao M
    Eur J Surg Oncol; 2014 Sep; 40(9):1143-50. PubMed ID: 24969958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis.
    Kinoshita Y; Hamasaki M; Yoshimura M; Matsumoto S; Sato A; Tsujimura T; Ueda H; Makihata S; Kato F; Iwasaki A; Nabeshima K
    Lung Cancer; 2018 Nov; 125():198-204. PubMed ID: 30429020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical genetic screening for compounds that preferentially inhibit growth of methylthioadenosine phosphorylase (MTAP)-deficient Saccharomyces cerevisiae.
    Kadariya Y; Tang B; Myers CB; Fukui J; Peterson JR; Kruger WD
    J Biomol Screen; 2011 Jan; 16(1):44-52. PubMed ID: 21131597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I study of L-alanosine using a daily x 3 schedule.
    Dosik GM; Stewart D; Valdivieso M; Burgess MA; Bodey GP
    Cancer Treat Rep; 1982 Jan; 66(1):73-6. PubMed ID: 7053269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of methylthioadenosine phosphorylase and BRCA-associated protein 1 immunohistochemistry in the diagnosis of malignant mesothelioma in effusion cytology specimens.
    Berg KB; Churg AM; Cheung S; Dacic S
    Cancer Cytopathol; 2020 Feb; 128(2):126-132. PubMed ID: 31821740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of the antimetabolite of L-alanosine, L-alanosyl-5-amino-4-imidazolecarboxylic acid ribonucleotide, in tumors and assessment of its inhibition of adenylosuccinate synthetase.
    Tyagi AK; Cooney DA
    Cancer Res; 1980 Dec; 40(12):4390-7. PubMed ID: 7438071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of MTAP expression is a negative prognostic marker in Ewing sarcoma family of tumors.
    Abrahao-Machado LF; Antunes B; Filippi RZ; Volc S; Boldrini E; Menezes WP; Reis RM; de Camargo OP
    Biomark Med; 2018 Jan; 12(1):35-44. PubMed ID: 29243509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The diagnostic value of immunohistochemically detected methylthioadenosine phosphorylase deficiency in malignant pleural mesotheliomas.
    Zimling ZG; Jørgensen A; Santoni-Rugiu E
    Histopathology; 2012 May; 60(6B):E96-105. PubMed ID: 22394205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.